Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007600,
umls-concept:C0017262,
umls-concept:C0018270,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0332437,
umls-concept:C0476089,
umls-concept:C1280500,
umls-concept:C1366557,
umls-concept:C1518174,
umls-concept:C1521828,
umls-concept:C1704256,
umls-concept:C1707520,
umls-concept:C2911684
|
pubmed:issue |
11
|
pubmed:dateCreated |
1990-6-14
|
pubmed:abstractText |
We examined the effects of transforming growth factor beta 1 (TGF-beta 1) on various aspects of the cell biology of human endometrial carcinoma (HEC) cell lines in vitro, as well as the expression of TGF-beta 1 mRNA by these cell lines. Cell lines from eight HEC tumors, representing a variety of histological subtypes, were studied in order to test the generality of conclusions regarding the effects of TGF-beta 1 on this particular tumor cell type. The growth of five HEC cell lines was inhibited by TGF-beta 1 (10 ng/ml), while growth of three cell lines was not inhibited. The effects on growth correlated with morphological alterations induced by TGF-beta 1; the cell lines with inhibited growth displayed a larger, flatter, more contact-inhibited phenotype, while the cell lines whose growth ws not inhibited showed few discernible morphological alterations in response to TGF-beta 1. Northern analysis of TGF-beta 1 mRNA levels revealed that the three HEC cell lines unresponsive to TGF-beta 1 treatment expressed relatively large amounts of TGF-beta 1. Correspondingly, the five HEC cell lines which responded to TGF-beta 1 with growth and morphological changes expressed much lower levels of TGF-beta 1 mRNA. These results suggest that the sensitivity of human HEC cell lines to TGF-beta 1 is variable and that this sensitivity is inversely correlated with the level of expression of TGF-beta 1.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3394-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2334934-Carcinoma,
pubmed-meshheading:2334934-Cell Division,
pubmed-meshheading:2334934-Female,
pubmed-meshheading:2334934-Humans,
pubmed-meshheading:2334934-RNA, Messenger,
pubmed-meshheading:2334934-Transforming Growth Factors,
pubmed-meshheading:2334934-Tumor Cells, Cultured,
pubmed-meshheading:2334934-Uterine Neoplasms
|
pubmed:year |
1990
|
pubmed:articleTitle |
Expression of transforming growth factor beta 1 by human endometrial carcinoma cell lines: inverse correlation with effects on growth rate and morphology.
|
pubmed:affiliation |
Department of Pathology, School of Medicine, University of North Carolina, Chapel Hill 27599.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|